Pharmaceutical companies by one-year price change
How far the share price has moved over the last 52 weeks.
Alnylam Pharmaceuticals has the lowest figure of the 61 pharmaceutical companies ranked by one-year price change, at -66.0%, followed by Ionis Pharmaceuticals (-63.6%) and Legend Biotech (-42.5%). Figures as of 18 Nov 2026, 17:47 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- Lowest
- Alnylam Pharmaceuticals-66.0%
- Median
- +26.9%
- Combined market value
- NOK 49.33T
- Countries
- 10
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | 1 year ↑ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | Alnylam PharmaceuticalsALNY · Health Care | -66.0% | NOK 197.5B | NOK 1,474.64 | 2.79% down | 66% down | ||
| 2 | Ionis PharmaceuticalsIONS · Health Care | -63.6% | NOK 44.5B | NOK 267.42 | 2.34% up | 64% down | ||
| 3 | Legend BiotechLEGN · Health Care | -42.5% | NOK 30.5B | NOK 157.22 | 0.68% up | 42% down | ||
| 4 | InsmedINSM · Health Care | -40.1% | NOK 257.3B | NOK 1,172.86 | 0.70% down | 40% down | ||
| 5 | Summit TherapeuticsSMMT · Health Care | -35.6% | NOK 82.8B | NOK 103.47 | 0.05% up | 36% down | ||
| 6 | ZoetisZTS · Health Care | -28.7% | NOK 334B | NOK 821.94 | 1.58% up | 29% down | ||
| 7 | ABIVAXABVX · Health Care | -27.3% | NOK 71.3B | NOK 814.38 | 2.34% up | 27% down | ||
| 8 | Madrigal PharmaceuticalsMDGL · Health Care | -24.0% | NOK 91.5B | NOK 3,940.75 | 3.65% down | 24% down | ||
| 9 | Cogent BiosciencesCOGT · Health Care | -20.3% | NOK 47.7B | NOK 274.11 | 1.54% up | 20% down | ||
| 10 | CytokineticsCYTK · Health Care | -20.3% | NOK 69.7B | NOK 500.58 | 0.01% down | 20% down | ||
| 11 | PTC TherapeuticsPTCT · Health Care | -20.2% | NOK 49B | NOK 586.12 | 0.18% up | 20% down | ||
| 12 | Abbott LaboratoriesABT · Health Care | -17.0% | NOK 1.76T | NOK 1,013.85 | 0.11% down | 17% down | ||
| 13 | Novo NordiskNVO · Health Care | -16.9% | NOK 1.69T | NOK 383.73 | 2.73% down | 17% down | ||
| 14 | Corcept TherapeuticsCORT · Health Care | -7.92% | NOK 72.5B | NOK 662.54 | 2.45% down | 8% down | ||
| 15 | Axsome TherapeuticsAXSM · Health Care | -7.37% | NOK 68.2B | NOK 1,296.25 | 1.63% down | 7% down | ||
| 16 | SanofiSNY · Health Care | -4.08% | NOK 1.1T | NOK 458.71 | 0.43% down | 4% down | ||
| 17 | GrifolsGRFS · Health Care | +1.41% | NOK 55.9B | NOK 82.10 | 1.85% down | 1% up | ||
| 18 | AstraZenecaAZN · Health Care | +2.41% | NOK 2.7T | NOK 1,739.45 | 1.54% down | 2% up | ||
| 19 | Dr. Reddy's LaboratoriesRDY · Health Care | +5.27% | NOK 121.3B | NOK 145.54 | 1.52% up | 5% up | ||
| 20 | GSKGSK · Health Care | +6.26% | NOK 947.9B | NOK 472.91 | 0.91% down | 6% up | ||
| 21 | Arrowhead PharmaceuticalsARWR · Health Care | +10.3% | NOK 59.7B | NOK 422.12 | 1.30% up | 10% up | ||
| 22 | BioMarin PharmaceuticalBMRN · Health Care | +11.3% | NOK 113.9B | NOK 587.81 | 3.65% up | 11% up | ||
| 23 | Rhythm PharmaceuticalsRYTM · Health Care | +13.0% | NOK 80B | NOK 1,154.40 | 2.14% up | 13% up | ||
| 24 | PfizerPFE · Health Care | +14.4% | NOK 1.56T | NOK 272.99 | 1.07% down | 14% up | ||
| 25 | BeOne MedicinesONC · Health Care | +16.8% | NOK 449.1B | NOK 3,931.73 | 1.84% down | 17% up | ||
| 26 | BridgeBio PharmaBBIO · Health Care | +17.2% | NOK 147.2B | NOK 755.59 | 1.50% up | 17% up | ||
| 27 | Elanco Animal HealthELAN · Health Care | +20.5% | NOK 129.9B | NOK 259.96 | 3.75% up | 20% up | ||
| 28 | United TherapeuticsUTHR · Health Care | +22.6% | NOK 239.8B | NOK 5,631.54 | 0.53% down | 23% up | ||
| 29 | NovartisNVS · Health Care | +25.0% | NOK 2.86T | NOK 1,512.06 | 1.97% down | 25% up | ||
| 30 | AbbVieABBV · Health Care | +25.7% | NOK 4.93T | NOK 2,790.33 | 1.69% down | 26% up | ||
| 31 | Vertex PharmaceuticalsVRTX · Health Care | +26.9% | NOK 1.32T | NOK 5,199.49 | 0.42% up | 27% up | ||
| 32 | Ascendis PharmaASND · Health Care | +27.8% | NOK 172.6B | NOK 2,631.34 | 0.11% up | 28% up | ||
| 33 | Mirum PharmaceuticalsMIRM · Health Care | +30.5% | NOK 58.3B | NOK 892.60 | 0.15% up | 31% up | ||
| 34 | Belite BioBLTE · Health Care | +31.0% | NOK 62.4B | NOK 1,535.61 | 0.45% up | 31% up | ||
| 35 | Bristol-Myers SquibbBMY · Health Care | +34.0% | NOK 1.19T | NOK 581.46 | 2.22% down | 34% up | ||
| 36 | Eli LillyLLY · Health Care | +34.9% | NOK 12.01T | NOK 13,478.14 | 1.77% down | 35% up | ||
| 37 | Regeneron PharmaceuticalsREGN · Health Care | +36.3% | NOK 951.8B | NOK 9,200.67 | 0.89% down | 36% up | ||
| 38 | Jazz PharmaceuticalsJAZZ · Health Care | +36.7% | NOK 153.3B | NOK 2,388.81 | 2.39% up | 37% up | ||
| 39 | Johnson & JohnsonJNJ · Health Care | +37.6% | NOK 6.44T | NOK 2,676.15 | 0.93% down | 38% up | ||
| 40 | Ligand PharmaceuticalsLGND · Health Care | +42.6% | NOK 58.3B | NOK 2,914.68 | 2.35% up | 43% up | ||
| 41 | Travere TherapeuticsTVTX · Health Care | +44.2% | NOK 47.7B | NOK 496.56 | 0.25% up | 44% up | ||
| 42 | Protagonist TherapeuticsPTGX · Health Care | +46.4% | NOK 79.3B | NOK 1,215.65 | 0.60% up | 46% up | ||
| 43 | Merck & CoMRK · Health Care | +50.8% | NOK 3.32T | NOK 1,345.58 | 3.17% down | 51% up | ||
| 44 | Takeda PharmaceuticalTAK · Health Care | +53.6% | NOK 662.7B | NOK 207.42 | 1.11% down | 54% up | ||
| 45 | AlkermesALKS · Health Care | +58.4% | NOK 76.3B | NOK 454.20 | 3.10% up | 58% up | ||
| 46 | Praxis Precision MedicinesPRAX · Health Care | +61.1% | NOK 83.6B | NOK 2,990.72 | 1.15% up | 61% up | ||
| 47 | GenmabGMAB · Health Care | +70.0% | NOK 307.8B | NOK 499.17 | 0.89% down | 70% up | ||
| 48 | Teva Pharmaceutical IndustriesTEVA · Health Care | +74.4% | NOK 478.2B | NOK 409.85 | 0.79% down | 74% up | ||
| 49 | Royalty PharmaRPRX · Health Care | +77.7% | NOK 386.3B | NOK 671.80 | 0.92% up | 78% up | ||
| 50 | Amneal PharmaceuticalsAMRX · Health Care | +83.3% | NOK 74.2B | NOK 213.04 | 4.07% up | 83% up | ||
| 51 | Edgewise TherapeuticsEWTX · Health Care | +88.2% | NOK 44.4B | NOK 405.83 | 0.40% down | 88% up | ||
| 52 | Roivant SciencesROIV · Health Care | +90.3% | NOK 271.7B | NOK 374.96 | 0.06% down | 90% up | ||
| 53 | ViatrisVTRS · Health Care | +95.5% | NOK 230.5B | NOK 201.07 | 1.44% up | 96% up | ||
| 54 | TG TherapeuticsTGTX · Health Care | +107% | NOK 97.1B | NOK 642.14 | 5.65% up | 107% up | ||
| 55 | Dianthus TherapeuticsDNTH · Health Care | +113% | NOK 47.6B | NOK 845.69 | 0.31% up | 113% up | ||
| 56 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | +126% | NOK 72.7B | NOK 925.89 | 0.44% up | 126% up | ||
| 57 | Definium TherapeuticsDFTX · Health Care | +169% | NOK 38.6B | NOK 282.15 | 0.92% down | 169% up | ||
| 58 | VeradermicsMANE · Health Care | +233% | NOK 50.7B | NOK 1,201.79 | 1.31% down | 233% up | ||
| 59 | Oruka TherapeuticsORKA · Health Care | +241% | NOK 64.4B | NOK 949.83 | 1.74% up | 241% up | ||
| 60 | Spyre TherapeuticsSYRE · Health Care | +286% | NOK 89.7B | NOK 944.11 | 3.83% up | 286% up | ||
| 61 | ErascaERAS · Health Care | +403% | NOK 45.2B | NOK 128.91 | 4.25% down | 403% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Sums are converted from US dollars at today's exchange rate (1 USD = 9.6927 NOK).
Questions and answers
Which pharmaceutical companies have the lowest one-year price change?
Alnylam Pharmaceuticals (-66.0%), Ionis Pharmaceuticals (-63.6%) and Legend Biotech (-42.5%) have the lowest one-year price change of the 61 pharmaceutical companies ranked here as of 18 Nov 2026, 17:47 UTC.
How many pharmaceutical companies are in this ranking?
61 are ranked by one-year price change.
What are these pharmaceutical companies worth together?
The 61 pharmaceutical companies ranked by one-year price change have a combined market value of NOK 49.33T as of 18 Nov 2026, 17:47 UTC.
What does ranking by one-year price change measure?
How far the share price has moved over the last 52 weeks.
Learn how this ranking works
All markets guides →- 52-week high and low: what the range tells you
A stock's 52-week high and low are the highest and lowest prices it reached over the past year. Where today's price sits in that range, from 0% at the low to 100% at the high, shows how the past year has gone. Sources differ on whether they use closing or intraday prices, so the same stock's range can differ slightly.
- Drawdown and recovery: why a 50% fall needs a 100% gain
A drawdown is how far a price has fallen from its previous peak, as a percentage of that peak. Recovery needs a larger gain than the fall, because the gain starts from a smaller base: a 20% drop needs a 25% rise to get back, a 50% drop needs 100%, and a 75% drop needs 300%.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Pharmaceutical companies by one-year price change”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=year-change
Underlying data: Yahoo Finance; SEC EDGAR.